Brief: Astrazeneca Opens Global Strategic R&D Center In Kendall Square, Massachusetts
BRIEF-Astrazeneca Opens Global Strategic R&D Center In Kendall Square, Massachusetts Oct 5 (Reuters) - AstraZeneca PLC AZN.L:
ASTRAZENECA OPENS NEW GLOBAL STRATEGIC RESEARCH AND DEVELOPMENT CENTER IN KENDALL SQUARE, CAMBRIDGE, MASSACHUSETTS
ASTRAZENECA - INVESTS $1 BILLION TO GROW MASSACHUSETTS WORKFORCE BY OVER 50%
Source text: ID:nBw9VyhGfa
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsAstraZeneca fends off lawsuit over alleged Soliris drug monopoly (updated)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly
Sofinnova closes €725 million fund to back European biotech expansion
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
UK Stocks-Factors to watch on November 16 (updated)